Oral therapies for the treatment of chronic diseases

Immunic AG develops selective, orally administered therapies for the treatment of chronic inflammatory and autoimmune diseases, including multiple sclerosis, ulcerative colitis and Crohn’s disease. There are currently several small molecule candidates in the development pipeline that are being tested in various phase 1, 2 and 3 studies worldwide.